BioLine Rx Ltd (BLRX)
0.3232
-0.22
(-40.71%)
USD |
NASDAQ |
Nov 21, 16:00
0.32
0.00 (0.00%)
Pre-Market: 09:28
BioLine Rx Max Drawdown (5Y): 97.41% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 97.41% |
| September 30, 2024 | 97.41% |
| August 31, 2024 | 97.41% |
| July 31, 2024 | 97.41% |
| June 30, 2024 | 97.41% |
| May 31, 2024 | 97.41% |
| April 30, 2024 | 97.41% |
| March 31, 2024 | 97.41% |
| February 29, 2024 | 97.41% |
| January 31, 2024 | 97.41% |
| December 31, 2023 | 97.41% |
| November 30, 2023 | 97.41% |
| October 31, 2023 | 97.41% |
| September 30, 2023 | 97.41% |
| August 31, 2023 | 97.41% |
| July 31, 2023 | 97.41% |
| June 30, 2023 | 97.41% |
| May 31, 2023 | 97.41% |
| April 30, 2023 | 97.41% |
| March 31, 2023 | 97.41% |
| February 28, 2023 | 97.41% |
| January 31, 2023 | 97.40% |
| December 31, 2022 | 97.40% |
| November 30, 2022 | 97.24% |
| October 31, 2022 | 97.22% |
| Date | Value |
|---|---|
| September 30, 2022 | 97.22% |
| August 31, 2022 | 97.22% |
| July 31, 2022 | 97.22% |
| June 30, 2022 | 97.22% |
| May 31, 2022 | 97.22% |
| April 30, 2022 | 97.22% |
| March 31, 2022 | 97.22% |
| February 28, 2022 | 97.22% |
| January 31, 2022 | 97.22% |
| December 31, 2021 | 97.22% |
| November 30, 2021 | 97.22% |
| October 31, 2021 | 97.22% |
| September 30, 2021 | 97.22% |
| August 31, 2021 | 97.22% |
| July 31, 2021 | 97.22% |
| June 30, 2021 | 97.22% |
| May 31, 2021 | 97.22% |
| April 30, 2021 | 97.22% |
| March 31, 2021 | 97.22% |
| February 28, 2021 | 97.22% |
| January 31, 2021 | 97.22% |
| December 31, 2020 | 97.22% |
| November 30, 2020 | 97.22% |
| October 31, 2020 | 97.22% |
| September 30, 2020 | 97.22% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.48%
Minimum
Nov 2019
97.41%
Maximum
Feb 2023
97.16%
Average
97.22%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| Compugen Ltd | 97.28% |
| Pluri Inc | 96.65% |
| XTL Biopharmaceuticals Ltd | 92.62% |
| Can Fite Biofarma Ltd | 99.32% |
| BiomX Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -52.45 |
| Beta (5Y) | 1.484 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.26% |
| Historical Sharpe Ratio (5Y) | -0.4201 |
| Historical Sortino (5Y) | -0.8584 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.39% |